EUCTR2022-003905-31-IT招募中1 期
Fully hybrid 18F-PSMA PET/MRI as one-stop approach for the diagnosis of clinicallysignificant prostate cancer - PET/MRI with 18F-PSMA
OSPEDALE SAN RAFFAELE0 个研究点目标入组 167 人开始时间: 2023年2月8日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 167
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •1) Patients 18 years of age or older, identified as suspects for clinically significant prostate cancer
- •2) Ability to undergo all protocol scrutiny
- •3) Ability to provide informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 83
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 84
排除标准
- •1) Previous diagnosis of prostate cancer
- •2) Contraindications to perform the MRI examination (e.g. claustrophobia, pacemaker, estimated GFR less than or equal to 50mls/min)
- •3) Contraindications to perform the prostate biopsy
研究者
相似试验
招募中
不适用
Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.Clinical Suspicion of Prostate CancerNCT06305390IRCCS San Raffaele167
撤回
2 期
18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate CancerProstate CancerNCT05815316IRCCS San Raffaele167
招募中
2 期
18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast CancerBreast Cancer FemaleLobular Breast CarcinomaPET/MRIAxillary LymphadenopathyLuminal a Breast CancerLuminal A Breast CancerNCT05982496Università Vita-Salute San Raffaele119
已完成
早期 1 期
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate CancerProstate NeoplasmProstate CancerNCT03232164University of Wisconsin, Madison126
已完成
早期 1 期
PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver CancerHepatocellular CarcinomaNCT04310540Mayo Clinic42